Video interview: Wis. rad seeks to boot colon cancer off top 10 list w/ CTC

University of Wisconsin (UW) School of Medicine and Public Health in Madison has bucked national CT colonography (CTC) non reimbursement policy and delivered the exam as a screening option for eligible patients since 2004. Credit for the unique program largely rests with Perry J. Pickhardt, MD, UW radiologist. The program also demonstrates the power of radiology leadership.

Radiologists can work with payers and clinicians to provide CT colonography as an option for eligible patients, insists Pickhardt. At UW, the effort has effectively increased overall screening rates.

Key to the program’s success is the support of the gastroenterology department. “Our gastroenterologists have seen how well CTC fits into our overall screening strategy and are no longer threatened by our presence,” says Pickhardt. Instead of viewing CTC and colonoscopy as competing procedures, gastroenterologists and radiologists are working toward the same goal: 100 percent colorectal cancer screening compliance.

The other essential player is the local payer community. Pickhardt and other UW stakeholders have educated local HMOs about CTC benefits and all cover the exam.

His advice for his colleagues is simple. “Until Medicare initiates coverage for CTC screening, other radiology practices could try to emulate our path by seeking out local reimbursement for CTC screening—using our experience as a positive precedent.”

For more details about the UW program, please watch the following video:

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.